AP258A - Solid dosage forms of almokalant and processes for manufacture thereof. - Google Patents

Solid dosage forms of almokalant and processes for manufacture thereof. Download PDF

Info

Publication number
AP258A
AP258A APAP/P/1991/000338A AP9100338A AP258A AP 258 A AP258 A AP 258A AP 9100338 A AP9100338 A AP 9100338A AP 258 A AP258 A AP 258A
Authority
AP
ARIPO
Prior art keywords
almokalant
tablet
tablets
composition according
solid dosage
Prior art date
Application number
APAP/P/1991/000338A
Other languages
English (en)
Other versions
AP9100338A0 (en
Inventor
Kjell Hjalmar Anderson
Per Johan Gunnar Lundberg
Leif Roger Simonsson
Karin Helena Johansson WINGSTRAND
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of AP9100338A0 publication Critical patent/AP9100338A0/xx
Application granted granted Critical
Publication of AP258A publication Critical patent/AP258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
APAP/P/1991/000338A 1990-12-07 1991-12-02 Solid dosage forms of almokalant and processes for manufacture thereof. AP258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (sv) 1990-12-07 1990-12-07 Solid dosage forms of a drug

Publications (2)

Publication Number Publication Date
AP9100338A0 AP9100338A0 (en) 1992-01-31
AP258A true AP258A (en) 1993-06-03

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000338A AP258A (en) 1990-12-07 1991-12-02 Solid dosage forms of almokalant and processes for manufacture thereof.

Country Status (27)

Country Link
EP (1) EP0560821A1 (es)
JP (1) JPH06503312A (es)
CN (1) CN1063039A (es)
AP (1) AP258A (es)
AU (1) AU8930791A (es)
BG (1) BG97851A (es)
CA (1) CA2097178A1 (es)
CZ (1) CZ103793A3 (es)
FI (1) FI932554L (es)
HU (1) HUT64217A (es)
IE (1) IE914137A1 (es)
IL (1) IL100150A0 (es)
IS (1) IS3788A7 (es)
LT (1) LTIP1717A (es)
MA (1) MA22355A1 (es)
MX (1) MX9102325A (es)
MY (1) MY106776A (es)
NO (1) NO932052D0 (es)
NZ (1) NZ240731A (es)
PT (1) PT99719A (es)
SE (1) SE9003902D0 (es)
SK (1) SK55693A3 (es)
TN (1) TNSN91117A1 (es)
TW (1) TW215057B (es)
WO (1) WO1992010172A1 (es)
YU (1) YU186891A (es)
ZA (1) ZA919264B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (de) 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322390A2 (en) * 1987-12-23 1989-06-28 Aktiebolaget Hässle Novel antiarrhythmic agents I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322390A2 (en) * 1987-12-23 1989-06-28 Aktiebolaget Hässle Novel antiarrhythmic agents I

Also Published As

Publication number Publication date
SK55693A3 (en) 1993-10-06
MA22355A1 (fr) 1992-07-01
FI932554A7 (fi) 1993-06-08
HUT64217A (en) 1993-12-28
BG97851A (en) 1994-04-29
TNSN91117A1 (fr) 1992-10-25
WO1992010172A1 (en) 1992-06-25
EP0560821A1 (en) 1993-09-22
FI932554L (fi) 1993-06-08
CZ103793A3 (en) 1994-02-16
NO932052L (no) 1993-06-04
JPH06503312A (ja) 1994-04-14
MX9102325A (es) 1992-06-01
YU186891A (sh) 1994-04-05
SE9003902D0 (sv) 1990-12-07
NO932052D0 (no) 1993-06-04
CN1063039A (zh) 1992-07-29
TW215057B (es) 1993-10-21
ZA919264B (en) 1992-08-26
AP9100338A0 (en) 1992-01-31
IE914137A1 (en) 1992-06-17
NZ240731A (en) 1993-10-26
CA2097178A1 (en) 1992-06-08
IS3788A7 (is) 1992-06-08
IL100150A0 (en) 1992-08-18
PT99719A (pt) 1992-10-30
HU9301670D0 (en) 1993-09-28
AU8930791A (en) 1992-07-08
MY106776A (en) 1995-07-31
LTIP1717A (en) 1995-07-25

Similar Documents

Publication Publication Date Title
US9931358B2 (en) Direct compression polymer tablet core
US6350471B1 (en) Tablet comprising a delayed release coating
US20020054903A1 (en) Direct compression polymer tablet core
JP4942271B2 (ja) 直接圧縮ポリマー錠剤コア
KR101120729B1 (ko) 서방 조성물
US7749536B2 (en) Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
US20030118647A1 (en) Extended release tablet of metformin
US5149523A (en) Polystyrenesulfonate-drug complex and solid dosage forms thereof
AP258A (en) Solid dosage forms of almokalant and processes for manufacture thereof.
EP0266707B1 (en) Sustained release labetalol tablet
US4940580A (en) Sustained release labetalol tablets
JP5124286B2 (ja) 徐放性製剤およびその製造方法
EP1458384A1 (en) Amlopidine bezylate tablets with improved stability
CA2481377A1 (en) Antihistamine-decongestant pharmaceutical compositions
CA2576135C (en) Direct compression polymer tablet core
KR20080093073A (ko) 지방족 아민 중합체의 약학 제제 및 그 제조 방법